Authors:
MOLNARKIMBER KL
STERMAN DH
CHANG M
KANG EH
ELBASH M
LANUTI M
ELSHAMI A
GELFAND K
WILSON JM
KAISER LR
ALBELDA SM
Citation: Kl. Molnarkimber et al., IMPACT OF PREEXISTING AND INDUCED HUMORAL AND CELLULAR IMMUNE-RESPONSES IN AN ADENOVIRUS-BASED GENE-THERAPY PHASE-I CLINICAL-TRIAL FOR LOCALIZED MESOTHELIOMA, Human gene therapy, 9(14), 1998, pp. 2121-2133
Authors:
KANG E
GELFAND K
KAISER LR
ALBELDA SM
MOLNARKIMBER KL
Citation: E. Kang et al., ADMINISTRATION OF RECOMBINANT ADENOVIRAL-BASED GENE-THERAPY INTRAPLEURALLY INDUCED A T(H)1 CELLULAR IMMUNE-RESPONSE IN MESOTHELIOMA PATIENTS, Cancer gene therapy, 4(6), 1997, pp. 36-36
Authors:
KUCHARCZUK JC
RANDAZZO B
CHANG MY
AMIN KM
ELSHAMI AA
STERMAN DH
RIZK NP
MOLNARKIMBER KL
BROWN SM
MACLEAN AR
LITZKY LA
FRASER NW
ALBELDA SM
KAISER LR
Citation: Jc. Kucharczuk et al., USE OF A REPLICATION-RESTRICTED HERPES-VIRUS TO TREAT EXPERIMENTAL HUMAN-MALIGNANT MESOTHELIOMA, Cancer research, 57(3), 1997, pp. 466-471
Authors:
MOLNARKIMBER KL
STERMAN DH
ELBASH M
ELSHAMI AA
ROBERTS JR
TREAT J
WILSON J
KAISER LR
ALBELDA SM
Citation: Kl. Molnarkimber et al., HUMAN ADENOVIRAL-BASED GENE-THERAPY FOR LOCALIZED MESOTHELIOMA INDUCED HUMORAL AND CELLULAR IMMUNE-RESPONSE, Cancer gene therapy, 3(6), 1996, pp. 38-38
Authors:
CHEN YQ
CHEN HH
RHOAD AE
WARNER L
CAGGIANO TJ
FAILLI A
ZHANG HZ
HSIAO CL
NAKANISHI K
MOLNARKIMBER KL
Citation: Yq. Chen et al., A PUTATIVE SIROLIMUS (RAPAMYCIN) EFFECTOR PROTEIN, Biochemical and biophysical research communications, 203(1), 1994, pp. 1-7
Authors:
MOLNARKIMBER KL
YONNO L
RHOAD A
WEICHMAN BM
HEASLIP RJ
Citation: Kl. Molnarkimber et al., INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION FROM ENDOTOXIN STIMULATED HUMAN MONOCYTES BY WAY-PDA-641 AND ROLIPRAM, The Journal of immunology, 150(8), 1993, pp. 295-295